期刊文献+

靶向TRAIL受体的抗肿瘤研究进展 被引量:5

Progress on targeting TRAIL’s receptor as antitumor strategy
原文传递
导出
摘要 细胞凋亡一般分为细胞外途径和细胞内途径。细胞内途径是在线粒体水平启动的细胞死亡,细胞外途径是通过位于细胞膜的死亡受体传导的细胞死亡信号而引起的细胞凋亡途径。肿瘤坏死因子相关的凋亡诱导配体(TRAIL)信号传导通路是指以TRAIL为配体,通过与死亡受体(DR4,DR5)结合而启动凋亡信号,最终诱导细胞凋亡。本文将对TRAIL信号传导通路与肿瘤治疗进行综述。 There exist two major apoptotic signaling pathways: the intrinsic mitochondria-mediated pathway, and the extrinsic death receptor-induced pathway. TNF-related apoptosis-inducing ligand (TRAIL), which is the ligand for death receptor 4 (DR4) and death receptor 5 (DR5) and induces apoptosis by ligation with DR4 or DR5. We review the characteristic of TRAIL and its receptors, the mechanism of apoptosis induced by TRAIL, the distribution of death receptors in cancer, and applications and prospects of TRAIL signaling pathway in the treatment of cancer.
作者 陈淑珍
出处 《药学学报》 CAS CSCD 北大核心 2009年第12期1336-1342,共7页 Acta Pharmaceutica Sinica
关键词 TRAIL 死亡受体 细胞凋亡 抗肿瘤作用 TRAIL death receptor apoptosis antitumor activity
  • 相关文献

参考文献2

二级参考文献28

  • 1杨磊,张莲英,陈蔚文,孔峰,张鹏举,胡晓燕,张建业,崔福爱.姜黄素对前列腺特异抗原基因表达的抑制[J].药学学报,2005,40(9):800-803. 被引量:6
  • 2Mohandas KM,Desai DC.Epidemiology of digestive tract cancers in India.Ⅴ.Large and small bowel[J].Indian J Gastroenterol,1999,18:118-121.
  • 3Moragoda L,Jaszewski R,Majumdar AP.Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells[J].Anticancer Res,2001,21:873-878.
  • 4Ranjan D,Johnston TD,Reddy KS,et al.Enhanced apoptosis mediates inhibition of EBV transformed lymphoblastoid cell line proliferation by curcumin[J].J Surg Res,1999,87:1-5.
  • 5Asok M,Carlos BR,Devasis C,et al.Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines[J].Oncogene,2001,20:7597-7609.
  • 6Dorai T,Cao YC,Dorai B,et al.Therapeutic potential of curcumin in human prostate cancer.Ⅲ.Curcumin inhibits proliferation,induces apoptosis,and inhibits angiogenesis of LNCaP prostate cancer cells in vivo[J].Prostate,2001,47:293-303.
  • 7Zou Z,Anisowicz A,Hendrix MJ,et al.Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells[J].Science,1994,263:526-529.
  • 8Maass N,Teffner M,Rosel F,et al.Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast[J].J Pathol,2001,195:321-326.
  • 9Domann FE,Rice JC,Hendrix MJ,et al.Epigenetic silencing of maspin gene expression in human breast cancers[J].Int J Cancer,2000,85:805-810.
  • 10Zou Z,Gao C,Nagaich AK,et al.p53 regulates the expression of the tumor suppressor gene maspin[J].J Biol Chem,2000,275:6051-6054.

共引文献5

同被引文献31

  • 1You-PingLiu,Quan-ShengLi,Yu-RongHuang,Chang-XiaoLiu.Tissue distribution and excretion of ^(125)I-lidamycin in mice and rats[J].World Journal of Gastroenterology,2005,11(21):3281-3284. 被引量:1
  • 2胡文献,毛伟芳,何超,张磊,黄学锋,杜卫东,方炳良.杭白菊增强TRAIL基因诱导大肠癌细胞凋亡及机制的实验研究[J].中国病理生理杂志,2006,22(4):742-747. 被引量:3
  • 3Eigo S, Hiroaki K, Kazunam T. Identification of a easpase - 3 - in- dependent role of pro - apoptosis factor Bak in TNF -α - reduced apoptosis[ J ]. FEBS Letters ,2002,528:63 - 69.
  • 4Hart LH, Zhao YS, Jia XQ. Mathematical modeling identified c - FLIP as apoptotic switch in death receptor induced apoptosis [ J ]. Apoptosis,2008,13 : 1198 - 1204.
  • 5Schneider P, Thome M, Bums K, et al. Receptors I(DR4) and 2 ( DIL5 ) signal FADD - dependent apoptosis and activate NF - kappa B[J]. Immunity,1997,7(6) :831 -836.
  • 6Grcco FA, Bonomi P, Crawford J, et al. Phase 2 study of mapatu- mumab, a fully human agonistie monoclonal antibody which targets and activates the TRAIL receptor - 1, in patients with advanced non - small cell lung cancer[EJ]. Lung Cancer,2008,61 ( 1 ) :82 -90.
  • 7Grand M. Patterns in .Java. John Wiley & Sons, 1999-05
  • 8孙鸣.基于JDBC的数据库连接池高效管理策略[EB/OL].http://www-900ibm.com/developer Works/cn/java/I-jdbcperform/index.shtml,.
  • 9Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995,3 (6) : 673-682.
  • 10Yoldas B, Ozer C, Ozen O, et al. Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer. Head Neck, 2011,33(9) : 1278-1284.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部